Cargando…

Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis

In this systematic review and meta-analysis, we sought to evaluate the prevalence of cardiac involvement in patients with COVID-19 using cardiac magnetic resonance imaging. A literature review was performed to investigate the left ventricular (LV) and right ventricular (RV) ejection fraction (EF), t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Shingo, Azuma, Mai, Fukui, Kazuki, Kodama, Sho, Nakayama, Naoki, Kitamura, Hideya, Hagiwara, Eri, Ogura, Takashi, Horita, Nobuyuki, Namkoong, Ho, Kimura, Kazuo, Tamura, Kouichi, Utsunomiya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925980/
https://www.ncbi.nlm.nih.gov/pubmed/35294611
http://dx.doi.org/10.1007/s00380-022-02055-6
_version_ 1784670140890087424
author Kato, Shingo
Azuma, Mai
Fukui, Kazuki
Kodama, Sho
Nakayama, Naoki
Kitamura, Hideya
Hagiwara, Eri
Ogura, Takashi
Horita, Nobuyuki
Namkoong, Ho
Kimura, Kazuo
Tamura, Kouichi
Utsunomiya, Daisuke
author_facet Kato, Shingo
Azuma, Mai
Fukui, Kazuki
Kodama, Sho
Nakayama, Naoki
Kitamura, Hideya
Hagiwara, Eri
Ogura, Takashi
Horita, Nobuyuki
Namkoong, Ho
Kimura, Kazuo
Tamura, Kouichi
Utsunomiya, Daisuke
author_sort Kato, Shingo
collection PubMed
description In this systematic review and meta-analysis, we sought to evaluate the prevalence of cardiac involvement in patients with COVID-19 using cardiac magnetic resonance imaging. A literature review was performed to investigate the left ventricular (LV) and right ventricular (RV) ejection fraction (EF), the prevalence of LV late gadolinium enhancement (LGE), pericardial enhancement, abnormality on T1 mapping, and T2 mapping/T2-weighted imaging (T2WI), and myocarditis (defined by modified Lake Louis criteria). Pooled mean differences (MD) between COVID-19 patients and controls for LVEF and RVEF were estimated using random-effects models. We included data from 10.462 patients with COVID-19, comprising 1.010 non-athletes and 9.452 athletes from 29 eligible studies. The meta-analysis showed a significant difference between COVID-19 patients and controls in terms of LVEF [MD = − 2.84, 95% confidence interval (CI) − 5.11 to − 0.56, p < 0.001] and RVEF (MD = − 2.69%, 95% CI − 4.41 to − 1.27, p < 0.001). However, in athletes, no significant difference was identified in LVEF (MD = − 0.74%, 95% CI − 2.41 to − 0.93, p = 0.39) or RVEF (MD = − 1.88%, 95% CI − 5.21 to 1.46, p = 0.27). In non-athletes, the prevalence of LV LGE abnormalities, pericardial enhancement, T1 mapping, T2 mapping/T2WI, myocarditis were 27.5% (95%CI 17.4–37.6%), 11.9% (95%CI 4.1–19.6%), 39.5% (95%CI 16.2–62.8%), 38.1% (95%CI 19.0–57.1%) and 17.6% (95%CI 6.3–28.9%), respectively. In athletes, these values were 10.8% (95%CI 2.3–19.4%), 35.4% (95%CI − 3.2 to 73.9%), 5.7% (95%CI − 2.9 to 14.2%), 1.9% (95%CI 1.1–2.7%), 0.9% (0.3–1.6%), respectively. Both LVEF and RVEF were significantly impaired in COVID-19 patients compared to controls, but not in athletes. In addition, the prevalence of myocardial involvement is not negligible in patients with COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-022-02055-6.
format Online
Article
Text
id pubmed-8925980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-89259802022-03-17 Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis Kato, Shingo Azuma, Mai Fukui, Kazuki Kodama, Sho Nakayama, Naoki Kitamura, Hideya Hagiwara, Eri Ogura, Takashi Horita, Nobuyuki Namkoong, Ho Kimura, Kazuo Tamura, Kouichi Utsunomiya, Daisuke Heart Vessels Original Article In this systematic review and meta-analysis, we sought to evaluate the prevalence of cardiac involvement in patients with COVID-19 using cardiac magnetic resonance imaging. A literature review was performed to investigate the left ventricular (LV) and right ventricular (RV) ejection fraction (EF), the prevalence of LV late gadolinium enhancement (LGE), pericardial enhancement, abnormality on T1 mapping, and T2 mapping/T2-weighted imaging (T2WI), and myocarditis (defined by modified Lake Louis criteria). Pooled mean differences (MD) between COVID-19 patients and controls for LVEF and RVEF were estimated using random-effects models. We included data from 10.462 patients with COVID-19, comprising 1.010 non-athletes and 9.452 athletes from 29 eligible studies. The meta-analysis showed a significant difference between COVID-19 patients and controls in terms of LVEF [MD = − 2.84, 95% confidence interval (CI) − 5.11 to − 0.56, p < 0.001] and RVEF (MD = − 2.69%, 95% CI − 4.41 to − 1.27, p < 0.001). However, in athletes, no significant difference was identified in LVEF (MD = − 0.74%, 95% CI − 2.41 to − 0.93, p = 0.39) or RVEF (MD = − 1.88%, 95% CI − 5.21 to 1.46, p = 0.27). In non-athletes, the prevalence of LV LGE abnormalities, pericardial enhancement, T1 mapping, T2 mapping/T2WI, myocarditis were 27.5% (95%CI 17.4–37.6%), 11.9% (95%CI 4.1–19.6%), 39.5% (95%CI 16.2–62.8%), 38.1% (95%CI 19.0–57.1%) and 17.6% (95%CI 6.3–28.9%), respectively. In athletes, these values were 10.8% (95%CI 2.3–19.4%), 35.4% (95%CI − 3.2 to 73.9%), 5.7% (95%CI − 2.9 to 14.2%), 1.9% (95%CI 1.1–2.7%), 0.9% (0.3–1.6%), respectively. Both LVEF and RVEF were significantly impaired in COVID-19 patients compared to controls, but not in athletes. In addition, the prevalence of myocardial involvement is not negligible in patients with COVID-19. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00380-022-02055-6. Springer Japan 2022-03-16 2022 /pmc/articles/PMC8925980/ /pubmed/35294611 http://dx.doi.org/10.1007/s00380-022-02055-6 Text en © Springer Japan KK, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Kato, Shingo
Azuma, Mai
Fukui, Kazuki
Kodama, Sho
Nakayama, Naoki
Kitamura, Hideya
Hagiwara, Eri
Ogura, Takashi
Horita, Nobuyuki
Namkoong, Ho
Kimura, Kazuo
Tamura, Kouichi
Utsunomiya, Daisuke
Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title_full Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title_fullStr Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title_full_unstemmed Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title_short Cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
title_sort cardiac involvement in coronavirus disease 2019 assessed by cardiac magnetic resonance imaging: a meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925980/
https://www.ncbi.nlm.nih.gov/pubmed/35294611
http://dx.doi.org/10.1007/s00380-022-02055-6
work_keys_str_mv AT katoshingo cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT azumamai cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT fukuikazuki cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT kodamasho cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT nakayamanaoki cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT kitamurahideya cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT hagiwaraeri cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT oguratakashi cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT horitanobuyuki cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT namkoongho cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT kimurakazuo cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT tamurakouichi cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis
AT utsunomiyadaisuke cardiacinvolvementincoronavirusdisease2019assessedbycardiacmagneticresonanceimagingametaanalysis